- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04649294
The Effect of High Dose Glucocorticoid Steroids on Myocardial Function
November 30, 2020 updated by: Hillel Yaffe Medical Center
Long term steroid exposure, as in Cushing's disease, causes myocardial dysfunction, hypertrophy and fibrosis in addition to causing obesity, hypertension and glucose intolerance.
The aim of our study was to verify if short-term high-dose exogenous steroid therapy adversely effects the heart.
Study Overview
Status
Completed
Detailed Description
Patients eligible for high dose steroid therapy due to inflammatory diseases were offered to participate in this study.
The minimal total intravenous dose was 375 mg prednisone, and the daily steroids were divided into 2-3 doses.
To determine the steroids' effect on myocardial function the echocardiographic studies included estimation of global and segmental longitudinal strain.
Each patient had a baseline echocardiographic study performed before high-dose steroid therapy was initiated and again immediately after it.
A follow-up echo study was performed after completion of a 3-month low-dose steroid therapy period.
The paired 2-tailed t-test was used to compare group means
Study Type
Observational
Enrollment (Actual)
23
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hadera, Israel
- Hillel Yaffe Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patient with inflammatory disease who needs high dose steroids according to there disease severity and welling to participate in observation study to see the effect od steroids taken on the myocaridal functions duering hospital stay
Description
Inclusion Criteria:
- Age above 18
- Patient with rheumatic disease that need high dose steroids due to exacerbation
- Patient whom echocardiographic study can be performed with a good quality
Exclusion Criteria:
- age below 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
determine the steroids' effect on myocardial function the echocardiographic studies included estimation of global and segmental longitudinal strain
Time Frame: two years
|
the aim of the study was to verify if the reported adverse effect of long-term endogenous cortisol excess on LV systolic and diastolic function occurs after short-term, high-dose, exogenous steroid therapy as well.Patients with inflammatory diseases in internal medicine department who needed treatment with high dose steroids recruited to the study baseline echocardiographic study performed before high-dose steroid therapy was initiated.
A second study was performed after completion of the high-dose protocol and scheduled for a third echocardiographic study after completion of a 3-month low-dose steroid therapy period or immediately after termination of steroid therapy if it was during the 3-month period .
global and segmental longitudinal strain measured by echo in addition to standard echo measures .the
aim to see if high dose steroids use accompanied by echocardiographic changes as seen in Cushing disease
|
two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2017
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
December 20, 2018
Study Registration Dates
First Submitted
October 24, 2020
First Submitted That Met QC Criteria
November 30, 2020
First Posted (Actual)
December 2, 2020
Study Record Updates
Last Update Posted (Actual)
December 2, 2020
Last Update Submitted That Met QC Criteria
November 30, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 0052-17
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High-dose Steroids, Myocardial Function, Longitudinal Strain
-
Hillel Yaffe Medical CenterUnknown